FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation
WASHINGTON, D.C. — The U.S. Food and Drug Administration granted approval for Amondys 45 (casimersen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed …
FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation Read More